PrimeX News

First Light News: Micron Reignites the AI Trade as Markets Eye US PCE
Thu, 25 Jun 2026 07:48:22 GMT
US Dollar Price Forecast: DXY Retests $101 on Triangle Breakout — Will GBP/USD and EUR/USD Break?
Thu, 25 Jun 2026 06:46:49 GMT
Gold vs. Bitcoin: BTC Price Tests $60,000 as Bear Flag Pressure Builds
Thu, 25 Jun 2026 06:33:51 GMT
Gold (XAUUSD) & Silver Price Forecast: Gold Breaks $3,980 as Silver Dives to $57 Amid Ceasefire — Bearish Turn?
Thu, 25 Jun 2026 06:27:09 GMT
Natural Gas and Oil Forecast: WTI Under $70 While Brent Tests $73 — NatGas Channel Momentum?
Thu, 25 Jun 2026 07:24:36 GMT
Nasdaq Index: Micron’s AI Outlook Ends Chip Selloff, Lifts Tech Stocks
Thu, 25 Jun 2026 07:13:18 GMT

First Light News: Trump Puts Pen to Paper & the Fed Comes in Hawkish
Thu, 18 Jun 2026 08:20:37 GMT
ECB, Bank of England Set to Hold Rates Unchanged Today
Thu, 11 Jun 2026 17:21:35 GMT
Nasdaq 100: Meta Falls as Amazon Slips, Microsoft, Alphabet Diverge
Wed, 29 Apr 2026 21:43:04 GMT
Hungary’s Euro Ambition Is a Long-term Bet Requiring Discipline, Credibility and Integration
Thu, 11 Jun 2026 17:22:50 GMT
A Divided Fed to Continue Favouring Easing Even as the Iran War Raises the Stakes
Thu, 11 Jun 2026 17:20:25 GMT
ECB Policy to Ultimately Be Determined by the Fallout from the Iran War
Thu, 11 Jun 2026 17:22:12 GMT

Seasonality and Event-Driven Trades in ETFs: How to Spot Recurring Trading Opportunities
Fri, 19 Jun 2026 23:26:11 GMT
Building and Risk-Managing Multi-Asset Portfolios with ETFs
Fri, 19 Jun 2026 20:08:58 GMT
What Really Drives ETF Performance: Rebalancing, Dividends, Fees, and Tracking Error
Tue, 23 Jun 2026 13:26:26 GMT
Trading Volume Explained: Why it Matters for Breakouts, Reversals and Trends
Wed, 10 Jun 2026 00:40:01 GMT
RSI Indicator Explained: How to Read Momentum and Time Trades in 2026
Wed, 03 Jun 2026 21:56:39 GMT
Fibonacci Retracements Explained: How to Spot Key Reversal Levels in 2026
Thu, 28 May 2026 12:22:53 GMT

Advertisement

Advertisement

CRDF

Cardiff Oncology, Inc. Common Stock

1.26

USD

+0.01

+0.80%

Jun 24, 16:00 UTC -4

Closed

exchange

Pre-Market

1.30

+0.04

+3.17%

CRDF News & Forecasts

featured

Cardiff Oncology, Inc. (CRDF) Discusses Updated Phase II CRDF-004 Data on Onvansertib in First-Line RAS-Mutated Metastatic Colorectal Cancer Transcript

featured

Cardiff Oncology Sues Nerviano As Analyst Backs Onvansertib Defense

featured

Cardiff Oncology: Market Dismisses Onvansertib's Potential In First-Line Colorectal Cancer

Advertisement

Advertisement

Advertisement